483
Allergan Sales, LLCAllergan Sales, LLC – FDA 483, Jul 9, 2010
Record Details
An FDA inspection of Allergan Inc. in Irvine, CA, from July 6-9, 2010, identified three observations. The firm failed to timely report serious and unexpected adverse drug experiences and did not submit annual periodic adverse drug experience reports or other annual reports within the required timeframes.
View Company Profile
ID · dc2754a0-383b-4aca-b94a-0cc7b5d6a4cb
Other documents for Allergan Sales, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.